IBDEI0W9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15127,1,3,0)
 ;;=3^Vesical Tenesmus
 ;;^UTILITY(U,$J,358.3,15127,1,4,0)
 ;;=4^R30.1
 ;;^UTILITY(U,$J,358.3,15127,2)
 ;;=^5019323
 ;;^UTILITY(U,$J,358.3,15128,0)
 ;;=Z85.46^^56^641^16
 ;;^UTILITY(U,$J,358.3,15128,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15128,1,3,0)
 ;;=3^Hx of Malig Neop of Prostate
 ;;^UTILITY(U,$J,358.3,15128,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,15128,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,15129,0)
 ;;=N18.1^^56^641^4
 ;;^UTILITY(U,$J,358.3,15129,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15129,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,15129,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,15129,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,15130,0)
 ;;=N18.2^^56^641^5
 ;;^UTILITY(U,$J,358.3,15130,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15130,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,15130,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,15130,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,15131,0)
 ;;=N18.3^^56^641^6
 ;;^UTILITY(U,$J,358.3,15131,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15131,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,15131,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,15131,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,15132,0)
 ;;=N18.4^^56^641^7
 ;;^UTILITY(U,$J,358.3,15132,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15132,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,15132,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,15132,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,15133,0)
 ;;=N18.5^^56^641^8
 ;;^UTILITY(U,$J,358.3,15133,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15133,1,3,0)
 ;;=3^Chr Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,15133,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,15133,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,15134,0)
 ;;=N18.6^^56^641^10
 ;;^UTILITY(U,$J,358.3,15134,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15134,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,15134,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,15134,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,15135,0)
 ;;=N18.9^^56^641^9
 ;;^UTILITY(U,$J,358.3,15135,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15135,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,15135,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,15135,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,15136,0)
 ;;=N17.8^^56^641^1
 ;;^UTILITY(U,$J,358.3,15136,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15136,1,3,0)
 ;;=3^Acute Kidney Failure,Other
 ;;^UTILITY(U,$J,358.3,15136,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,15136,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,15137,0)
 ;;=N25.89^^56^641^17
 ;;^UTILITY(U,$J,358.3,15137,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15137,1,3,0)
 ;;=3^Impaired Renal Tubular Function Disorder NEC
 ;;^UTILITY(U,$J,358.3,15137,1,4,0)
 ;;=4^N25.89
 ;;^UTILITY(U,$J,358.3,15137,2)
 ;;=^5015618
 ;;^UTILITY(U,$J,358.3,15138,0)
 ;;=N27.1^^56^641^27
 ;;^UTILITY(U,$J,358.3,15138,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15138,1,3,0)
 ;;=3^Small Kidney,Bilateral
 ;;^UTILITY(U,$J,358.3,15138,1,4,0)
 ;;=4^N27.1
 ;;^UTILITY(U,$J,358.3,15138,2)
 ;;=^5015624
 ;;^UTILITY(U,$J,358.3,15139,0)
 ;;=N20.1^^56^641^3
 ;;^UTILITY(U,$J,358.3,15139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15139,1,3,0)
 ;;=3^Calculus of Ureter
 ;;^UTILITY(U,$J,358.3,15139,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,15139,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,15140,0)
 ;;=N28.1^^56^641^19
 ;;^UTILITY(U,$J,358.3,15140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15140,1,3,0)
 ;;=3^Kidney Cyst,Acquired
 ;;^UTILITY(U,$J,358.3,15140,1,4,0)
 ;;=4^N28.1
 ;;^UTILITY(U,$J,358.3,15140,2)
 ;;=^270380
